Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
7.57
+0.44 (6.17%)
Sep 8, 2026, 1:00 PM EDT - Market open
Entrada Therapeutics Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 4.69 | 5.74 | 25.42 | 61.52 | 79.48 | 172.22 | 210.78 | 215.23 | 239.4 | 162.87 | 129.01 | 87.17 | 43.43 | 25.26 | - | - | - | - | - | - |
Revenue Growth | -94.10% | -96.67% | -87.94% | -71.42% | -66.80% | 5.74% | 63.38% | 146.92% | 451.22% | 544.79% | - | - | - | - | - | - | - | - | - | - |
Gross Profit Gross Profit Growth | -134.36 | -135.81 | -115.15 | -80.2 | -55.14 | 43.45 | 85.48 | 95.04 | 128.27 | 57.48 | 29.13 | -0.11 | -40.62 | -48.73 | -66.61 | -86.85 | -67.89 | -51.64 | -35.93 | - |
Operating Income Operating Income Growth | -174.63 | -176.51 | -156 | -121.56 | -96.16 | 4.11 | 47.01 | 57.78 | 93.45 | 23.73 | -3.16 | -33.65 | -73.59 | -80.88 | -97.25 | -90.13 | -78.56 | -64.89 | -51.13 | -41.32 |
Net Income Net Income Growth | -165.78 | -166.12 | -143.75 | -103.46 | -73.35 | 24.78 | 65.63 | 54.95 | 104.44 | 23.49 | -6.69 | -21.77 | -82.37 | -79.62 | -94.62 | -88.43 | -77.73 | -64.45 | -51.16 | -41.38 |
Earnings Per Share EPS Growth | -3.97 | -4.00 | -3.47 | -2.52 | -1.79 | 0.60 | 1.68 | 1.55 | 3.04 | 0.70 | -0.20 | -0.67 | -2.57 | -2.53 | -3.02 | -3.08 | -3.66 | -4.68 | -8.16 | -31.58 |
EPS Growth | - | - | - | - | - | -14.24% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 223.01 | 254.86 | 295.7 | 326.84 | 354.01 | 382.52 | 420 | 449.34 | 469.75 | 327.41 | 351.97 | 353.58 | 376.79 | 411.63 | 188.71 | 215.57 | 244.25 | 263.9 | 291.06 | 122.17 |
Total Debt Total Debt Growth | 48.54 | 49.75 | 50.93 | 52.4 | 54.74 | 57 | 59.21 | 61.31 | 64.44 | 66.43 | 68.23 | 69.07 | 73.03 | 16.23 | 25.94 | 27.95 | 29.92 | 31.86 | - | - |
Net Cash (Debt) Net Cash Growth | 174.46 | 205.11 | 244.77 | 274.44 | 299.27 | 325.52 | 360.79 | 388.03 | 405.3 | 260.98 | 283.74 | 284.51 | 303.76 | 395.41 | 162.78 | 187.62 | 214.34 | 232.05 | 291.06 | 122.17 |
Net Cash Growth | -41.70% | -36.99% | -32.16% | -29.27% | -26.16% | 24.73% | 27.16% | 36.39% | 33.43% | -34.00% | 74.31% | 51.64% | 41.72% | 70.40% | -44.08% | 53.57% | 56.51% | 494.30% | 645.46% | - |
Net Cash Per Share Net Cash Per Share Growth | 4.18 | 4.93 | 5.92 | 6.66 | 7.30 | 8.02 | 9.25 | 10.92 | 11.84 | 7.75 | 8.59 | 8.74 | 9.48 | 12.52 | 5.20 | 6.54 | 10.09 | 16.86 | 46.44 | 93.21 |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -134.67 | -131.7 | -128.51 | -127.91 | -123.87 | -54.55 | -41.56 | -13.97 | -14.19 | -89.12 | 139.8 | 116.51 | 113.52 | 130.6 | -93.79 | -87.02 | -73.62 | -63.52 | -50.86 | -36.95 |
Capital Expenditures CapEx Growth | 0.32 | 0.06 | -1.04 | -1.88 | -2.69 | -3.46 | -3.16 | -3.5 | -4.31 | -4.78 | -5.61 | -5.35 | -4.71 | -3.96 | -2.89 | -3.5 | -3.5 | -4.27 | -4.58 | -4.7 |
Free Cash Flow Free Cash Flow Growth | -134.35 | -131.64 | -129.55 | -129.8 | -126.56 | -58.01 | -44.72 | -17.46 | -18.5 | -93.9 | 134.19 | 111.17 | 108.81 | 126.64 | -96.67 | -90.52 | -77.11 | -67.78 | -55.44 | -41.65 |
Free Cash Flow Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Gross Margin | - | - | - | -130.36% | -69.38% | 25.23% | 40.55% | 44.16% | 53.58% | 35.29% | 22.58% | -0.13% | -93.52% | -192.92% | - | - | - | - | - | - |
Operating Margin | -3726.53% | -3076.18% | -613.66% | -197.59% | -121.00% | 2.38% | 22.30% | 26.85% | 39.04% | 14.57% | -2.45% | -38.60% | -169.45% | -320.18% | - | - | - | - | - | - |
Pretax Margin | -3520.25% | -2878.29% | -561.84% | -169.85% | -96.77% | 13.82% | 31.54% | 35.51% | 46.11% | 24.87% | 9.34% | -24.98% | -149.60% | -301.14% | - | - | - | - | - | - |
Profit Margin | -3537.73% | -2895.05% | -565.48% | -168.17% | -92.30% | 14.39% | 31.14% | 25.53% | 43.63% | 14.42% | -5.18% | -24.98% | -189.66% | -315.20% | - | - | - | - | - | - |
FCF Margin | -2867.07% | -2294.20% | -509.63% | -210.98% | -159.24% | -33.68% | -21.21% | -8.11% | -7.73% | -57.65% | 104.01% | 127.53% | 250.55% | 501.36% | - | - | - | - | - | - |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
PE Ratio | - | - | - | - | - | 13.00 | 9.33 | 10.23 | 4.79 | 19.51 | - | - | - | - | - | - | - | - | - | - |
P/FCF Ratio | - | - | - | - | - | - | - | - | - | - | 3.75 | 4.72 | 4.62 | 3.79 | - | - | - | - | - | - |
PS Ratio | 56.60 | 79.18 | 14.50 | 3.35 | 2.98 | 1.87 | 2.90 | 2.61 | 2.09 | 2.81 | 3.90 | 6.03 | 11.57 | 18.99 | - | - | - | - | - | - |